Advertisement

Assessing the Older Cancer Patient

  • Melissa Cohen
  • David Reuben
  • Arash Naeim
Chapter

By 2030, one in every five individuals will be over the age of 65. Because the incidence of cancer increases with age, over 60% of all new cancer cases and 80% of deaths from cancer occur in people over 65 years of age in the United States and Europe [1–3]. Despite recent advances in geriatric care, elders still remain at risk for adverse events in all settings where cancer is treated. Because elderly patients are largely underrepresented in large cooperative trials [4, 5], there is limited evidence-based information for decision making to help guide the oncologist when caring for the older cancer patient. This can result in either suboptimal or overly toxic treatment.

Keywords

National Comprehensive Cancer Network Geriatric Assessment Frailty Index Comprehensive Geriatric Assessment Geriatric Syndrome 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Jemal A, et al. Cancer statistics. CA Cancer J Clin 2008;58(2):71–96.PubMedGoogle Scholar
  2. 2.
    Balducci L, Beghe C. Cancer and age in the USA. Crit Rev Oncol Hematol 2001;37(2):137–45.PubMedGoogle Scholar
  3. 3.
    Monfardini S, Balducci L. A comprehensive geriatric assessment (CGA) is necessary for the study and the management of cancer in the elderly. Eur J Cancer 1999;35(13):1771–2.PubMedGoogle Scholar
  4. 4.
    Murthy VH, Krumholz HM, Gross CP. Participation in cancer clinical trials: Race-, sex-, and age-based disparities. J Am Med Assoc 2004;291(22):2720–6.Google Scholar
  5. 5.
    Hutchins LF, et al. Underrepresentation of patients 65 years of age or older in cancer-treatment trials. N Engl J Med 1999;341(27):2061–7.PubMedGoogle Scholar
  6. 6.
    Balducci L, Extermann M. Management of cancer in the older person: A practical approach. Oncologist 2000;5(3):224–37.PubMedGoogle Scholar
  7. 7.
    Reuben DB. Geriatric assessment in oncology. Cancer 1997;80(7):1311–6.PubMedGoogle Scholar
  8. 8.
    Reuben DB, et al. A randomized clinical trial of outpatient comprehensive geriatric assessment coupled with an intervention to increase adherence to recommendations. J Am Geriatr Soc 1999;47(3):269–76.PubMedGoogle Scholar
  9. 9.
    Stuck AE, et al. Comprehensive geriatric assessment: A meta-analysis of controlled trials. Lancet 1993;342(8878):1032–6.PubMedGoogle Scholar
  10. 10.
    Thomas DR, Brahan R. Haywood BP. Inpatient community-based geriatric assessment reduces subsequent mortality. J Am Geriatr Soc 1993;41(2):101–4.PubMedGoogle Scholar
  11. 11.
    Rubenstein LZ, et al. Effectiveness of a geriatric evaluation unit. A randomized clinical trial. N Engl J Med 1984;311(26):1664–70.PubMedGoogle Scholar
  12. 12.
    Tinetti ME, et al. A multifactorial intervention to reduce the risk of falling among elderly people living in the community. N Engl J Med 1994;331(13):821–7.PubMedGoogle Scholar
  13. 13.
    Inouye SK, et al. A multicomponent intervention to prevent delirium in hospitalized older patients. N Engl J Med 1999;340(9):669–76.PubMedGoogle Scholar
  14. 14.
    Cohen HJ, et al. A controlled trial of inpatient and outpatient geriatric evaluation and management. N Engl J Med 2002;346(12):905–12.PubMedGoogle Scholar
  15. 15.
    Balducci L, et al. Senior adult oncology clinical practice guidelines in oncology. J Natl Compr Canc Netw 2005;3(4):572–90.PubMedGoogle Scholar
  16. 16.
    Hurria A, et al. Geriatric assessment for oncologists: Rationale and future directions. Crit Rev Oncol Hematol 2006;59(3):211–7.PubMedGoogle Scholar
  17. 17.
    Balducci L, Beghe C. The application of the principles of geriatrics to the management of the older person with cancer. Crit Rev Oncol Hematol 2000;35(3):147–54.PubMedGoogle Scholar
  18. 18.
    Extermann M, et al. A comprehensive geriatric intervention detects multiple problems in older breast cancer patients. Crit Rev Oncol Hematol 2004;49(1):69–75.PubMedGoogle Scholar
  19. 19.
    Repetto L, Pietropaolo M, Gianni W. Comprehensive geriatric assessment in oncology: Pro. Tumori 2002;88(1 Suppl 1):S101–2; discussion S105.Google Scholar
  20. 20.
    Repetto L, Balducci L. A case for geriatric oncology. Lancet Oncol 2002;3(5):289–97.PubMedGoogle Scholar
  21. 21.
    Repetto L, et al. Geriatric oncology: A clinical approach to the older patient with cancer. Eur J Cancer 2003;39(7):870–80.Google Scholar
  22. 22.
    Extermann M, et al. Use of comprehensive geriatric assessment in older cancer patients: Recommendations from the task force on CGA of the International Society of Geriatric Oncology (SIOG). Crit Rev Oncol Hematol 2005;55(3):241–52.PubMedGoogle Scholar
  23. 23.
    Balducci L, Beghe C. Pharmacology of chemotherapy in the older cancer patient. Cancer Control 1999;6(5):466–70.PubMedGoogle Scholar
  24. 24.
    Walter LC, Covinsky KE. Cancer screening in elderly patients: A framework for individualized decision making. J Am Med Assoc 2001;285(21):2750–6.Google Scholar
  25. 25.
    Rodin MB, Mohile SG. A practical approach to geriatric assessment in oncology. J Clin Oncol 2007;25(14):1936–44.PubMedGoogle Scholar
  26. 26.
    Ingram SS, et al. Comprehensive assessment of the elderly cancer patient: The feasibility of self-report methodology. J Clin Oncol 2002;20(3):770–5.Google Scholar
  27. 27.
    Extermann M, et al. Comorbidity and functional status are independent in older cancer patients. J Clin Oncol 1998;16(4):1582–7.PubMedGoogle Scholar
  28. 28.
    Overcash J., Prediction of falls in older adults with cancer: A preliminary study. Oncol Nurs Forum 2007;34(2):341–6.PubMedGoogle Scholar
  29. 29.
    Terret C, Albrand G, Droz JP. Geriatric assessment in elderly patients with prostate cancer. Clin Prostate Cancer 2004;2(4):236–40.PubMedGoogle Scholar
  30. 30.
    Saliba D, et al. The Vulnerable Elders Survey: A tool for identifying vulnerable older people in the community. J Am Geriatr Soc 2001;49(12):1691–9.PubMedGoogle Scholar
  31. 31.
    Hurria A, et al. Identifying vulnerable older adults with cancer: Integrating geriatric assessment into oncology practice. J Am Geriatr Soc 2007;55(10):1604–8.PubMedGoogle Scholar
  32. 32.
    Hurria A, et al. Developing a cancer-specific geriatric assessment: A feasibility study. Cancer 2005;104(9):1998–2005.Google Scholar
  33. 33.
    Richardson J. The Easy-Care assessment system and its appropriateness for older people. Nurs Older People. 2001;13(7):17–9.PubMedGoogle Scholar
  34. 34.
    Fried LP, et al. Risk factors for 5-year mortality in older adults: The Cardiovascular Health Study. J Am Med Assoc 1998;279(8):585–92.Google Scholar
  35. 35.
    Rockwood K, Andrew M, Mitnitski A. A comparison of two approaches to measuring frailty in elderly people. J Gerontol A Biol Sci Med Sci 2007;62(7):738–43.PubMedGoogle Scholar
  36. 36.
    Fried LP, et al. Association of comorbidity with disability in older women: The Women's Health and Aging Study. J Clin Epidemiol 1999;52(1):27–37.Google Scholar
  37. 37.
    Extermann M. Measuring comorbidity in older cancer patients. Eur J Cancer 2000;36(4):453–71.PubMedGoogle Scholar
  38. 38.
    Satariano WA, Ragland DR. The effect of comorbidity on 3-year survival of women with primary breast cancer. Ann Intern Med 1994;120(2):104–10.PubMedGoogle Scholar
  39. 39.
    Yancik R, et al. Perspectives on comorbidity and cancer in older patients: Approaches to expand the knowledge base. J Clin Oncol 2001;19(4):1147–51.PubMedGoogle Scholar
  40. 40.
    Piccirillo JF, et al. The changing prevalence of comorbidity across the age spectrum. Crit Rev Oncol Hematol 2008;67(2):124–32.PubMedGoogle Scholar
  41. 41.
    Piccirillo JF, et al. Prognostic importance of comorbidity in a hospital-based cancer registry. J Am Med Assoc 2004;291(20):2441–7.Google Scholar
  42. 42.
    Charlson ME, et al. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chronic Dis 1987;40(5):373–83.Google Scholar
  43. 43.
    Beddhu S, et al. A simple comorbidity scale predicts clinical outcomes and costs in dialysis patients. Am J Med 2000;108(8):609–13.PubMedGoogle Scholar
  44. 44.
    Miller MD, et al. Rating chronic medical illness burden in geropsychiatric practice and research: Application of the Cumulative Illness Rating Scale. Psychiatry Res 1992;41(3):237–48.Google Scholar
  45. 45.
    Mossey JM, Shapiro E. Self-rated health: A predictor of mortality among the elderly. Am J Public Health 1982;72(8):800–8.PubMedGoogle Scholar
  46. 46.
    Idler EL, Kasl S. Health perceptions and survival: Do global evaluations of health status really predict mortality? J Gerontol 1991;46(2):S55–65.PubMedGoogle Scholar
  47. 47.
    Scott WK, et al. Functional health status as a predictor of mortality in men and women over 65. J Clin Epidemiol 1997;50(3):291–6.PubMedGoogle Scholar
  48. 48.
    Inouye SK, et al. Importance of functional measures in predicting mortality among older hospitalized patients. J Am Med Assoc 1998;279(15):1187–93.Google Scholar
  49. 49.
    Ostchega Y, et al. The prevalence of functional limitations and disability in older persons in the US: Data from the National Health and Nutrition Examination Survey III. J Am Geriatr Soc 2000;48(9):1132–5.PubMedGoogle Scholar
  50. 50.
    Crimmins EM, Saito Y, Reynolds SL. Further evidence on recent trends in the prevalence and incidence of disability among older Americans from two sources: The LSOA and the NHIS. J Gerontol B Psychol Sci Soc Sci 1997;52(2):S59–71.PubMedGoogle Scholar
  51. 51.
    Oken MM, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 1982;5(6):649–55.PubMedGoogle Scholar
  52. 52.
    Extermann M. Studies of comprehensive geriatric assessment in patients with cancer. Cancer Control 2003;10(6):463–8.PubMedGoogle Scholar
  53. 53.
    Repetto L, et al. Comprehensive geriatric assessment adds information to Eastern Cooperative Oncology Group performance status in elderly cancer patients: An Italian Group for Geriatric Oncology Study. J Clin Oncol 2002;20(2):494–502.PubMedGoogle Scholar
  54. 54.
    Katz S, et al. Progress in development of the index of ADL. Gerontologist 1970;10(1):20–30.PubMedGoogle Scholar
  55. 55.
    Carreca I, Balducci L, Extermann M. Cancer in the older person. Cancer Treat Rev 2005;31(5):380–402.PubMedGoogle Scholar
  56. 56.
    Avlund K, Schultz-Larsen K, Kreiner S. The measurement of instrumental ADL: Content validity and construct validity. Aging (Milano) 1993;5(5):371–83.Google Scholar
  57. 57.
    Extermann M, et al. Predictors of tolerance to chemotherapy in older cancer patients: A prospective pilot study. Eur J Cancer 2002;38(11):1466–73.PubMedGoogle Scholar
  58. 58.
    Extermann M. Older patients, cognitive impairment, and cancer: An increasingly frequent triad. J Natl Compr Canc Netw 2005;3(4):593–6.PubMedGoogle Scholar
  59. 59.
    Balducci L, et al. Comprehensive Geriatric Oncology. Taylor and Francis, Boca Raton, FL. 2004.Google Scholar
  60. 60.
    Helmer C, et al. Mortality with dementia: Results from a French prospective community-based cohort. Am J Epidemiol 2001;154(7):642–8.PubMedGoogle Scholar
  61. 61.
    Elie M, et al. Prevalence and detection of delirium in elderly emergency department patients. Can Med Assoc J 2000;163(8):977–81.Google Scholar
  62. 62.
    Inouye SK, et al. Does delirium contribute to poor hospital outcomes? A three-site epidemiologic study. J Gen Intern Med 1998;13(4):234–42.PubMedGoogle Scholar
  63. 63.
    Elie M, et al. Delirium risk factors in elderly hospitalized patients. J Gen Intern Med 1998;13(3):204–12.PubMedGoogle Scholar
  64. 64.
    Vigliani MC, et al. Dementia following treatment of brain tumors with radiotherapy administered alone or in combination with nitrosourea-based chemotherapy: A clinical and pathological study. J Neurooncol 1999;41(2):137–49.PubMedGoogle Scholar
  65. 65.
    Schagen SB, et al. Cognitive deficits after postoperative adjuvant chemotherapy for breast carcinoma. Cancer 1999;85(3):640–50.PubMedGoogle Scholar
  66. 66.
    Unutzer J, et al. Depressive symptoms and mortality in a prospective study of 2,558 older adults. Am J Geriatr Psychiatry 2002;10(5):521–30.PubMedGoogle Scholar
  67. 67.
    Mulsant BH, Ganguli M. Epidemiology and diagnosis of depression in late life. J Clin Psychiatry 1999;60(Suppl 20):9–15.PubMedGoogle Scholar
  68. 68.
    Lebowitz BD, et al. Diagnosis and treatment of depression in late life. Consensus statement update. J Am Med Assoc 1997;278(14):1186–90.Google Scholar
  69. 69.
    Aapro M, Extermann M, Repetto L. Evaluation of the elderly with cancer. Ann Oncol 2000;11(Suppl 3):223–9.PubMedGoogle Scholar
  70. 70.
    Yesavage JA, et al. Development and validation of a geriatric depression screening scale: A preliminary report. J Psychiatr Res 1982;17(1):37–49.PubMedGoogle Scholar
  71. 71.
    Tinetti ME, Williams CS. Falls, injuries due to falls, and the risk of admission to a nursing home. N Engl J Med 1997;337(18):1279–84.PubMedGoogle Scholar
  72. 72.
    Hilkens PH, MJ ven den Bent. Chemotherapy-induced peripheral neuropathy. J Peripher Nerv Syst. 1997;2(4):350–61.PubMedGoogle Scholar
  73. 73.
    Reuben D. Principles of geriatric assessment. In: W. Hazzard et al. (Editors), Principles of Geriatric Medicine and Gerontology. McGraw-Hill, New York. 2003.Google Scholar
  74. 74.
    Quillen DA. Common causes of vision loss in elderly patients. Am Fam Phys 1999;60(1):99–108.Google Scholar
  75. 75.
    Rahmani B, et al. The cause-specific prevalence of visual impairment in an urban population. The Baltimore Eye Survey. Ophthalmology 1996;103(11):1721–6.Google Scholar
  76. 76.
    Ivers RQ, et al. Visual impairment and risk of hip fracture. Am J Epidemiol 2000;152(7):633–9.PubMedGoogle Scholar
  77. 77.
    Kelly M. Medications and the visually impaired elderly. Geriatr Nurs 1996;17(2):60–2.PubMedGoogle Scholar
  78. 78.
    Caban AJ, et al. Prevalence of concurrent hearing and visual impairment in US adults: The National Health Interview Survey, 1997–2002. Am J Public Health 2005;95(11):1940–2.PubMedGoogle Scholar
  79. 79.
    Cohen-Mansfield J, Taylor JW. Hearing aid use in nursing homes. Part 1: Prevalence rates of hearing impairment and hearing aid use. J Am Med Dir Assoc 2004;5(5):283–8.PubMedGoogle Scholar
  80. 80.
    Norris CH. Drugs affecting the inner ear. A review of their clinical efficacy, mechanisms of action, toxicity, and place in therapy. Drugs 1988;36(6):754–72.PubMedGoogle Scholar
  81. 81.
    Ravi R, Somani SM, Rybak LP. Mechanism of cisplatin ototoxicity: Antioxidant system. Pharmacol Toxicol 1995;76(6):386–94.PubMedGoogle Scholar
  82. 82.
    Hansen SW. Late-effects after treatment for germ-cell cancer with cisplatin, vinblastine, and bleomycin. Dan Med Bull 1992;39(5):391–9.PubMedGoogle Scholar
  83. 83.
    Humes LE. Speech understanding in the elderly. J Am Acad Audiol. 1996;7(3):161–7.PubMedGoogle Scholar
  84. 84.
    Newman AB, et al. Weight change in old age and its association with mortality. J Am Geriatr Soc 2001;49(10):1309–18.PubMedGoogle Scholar
  85. 85.
    Aslani A, et al. The predictive value of body protein for chemotherapy-induced toxicity. Cancer 2000;88(4):796–803.PubMedGoogle Scholar
  86. 86.
    Dewys WD, et al. Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group. Am J Med 1980;69(4):491–7.Google Scholar
  87. 87.
    Osoba D, et al. Effect of postchemotherapy nausea and vomiting on health-related quality of life. The Quality of Life and Symptom Control Committees of the National Cancer Institute of Canada Clinical Trials Group. Support Care Cancer 1997;5(4):307–13.PubMedGoogle Scholar
  88. 88.
    Kris MG, et al. Controlling delayed vomiting: Double-blind, randomized trial comparing placebo, dexamethasone alone, and metoclopramide plus dexamethasone in patients receiving cisplatin. J Clin Oncol 1989;7(1):108–14.PubMedGoogle Scholar
  89. 89.
    Diokno AC. Epidemiology and psychosocial aspects of incontinence. Urol Clin North Am 1995;22(3):481–5.PubMedGoogle Scholar
  90. 90.
    Voigt JC, Kenefick JS. Sacrococcygeal chordoma presenting with stress incontinence of urine. S Afr Med J 1971;45(20):557.PubMedGoogle Scholar
  91. 91.
    Ehrlich RM, Walsh GO. Urinary incontinence secondary to brain neoplasm. Urology 1973;1(3):249–50.PubMedGoogle Scholar
  92. 92.
    Diokno AC, Brown MB, Herzog AR. Relationship between use of diuretics and continence status in the elderly. Urology 1991;38(1):39–42.PubMedGoogle Scholar
  93. 93.
    Savard J, Morin CM. Insomnia in the context of cancer: A review of a neglected problem. J Clin Oncol 2001;19(3):895–908.PubMedGoogle Scholar
  94. 94.
    Love RR, et al. Symptoms associated with tamoxifen treatment in postmenopausal women. Arch Intern Med 1991;151(9):1842–7.PubMedGoogle Scholar
  95. 95.
    Dorrepaal KL, Aaronson NK, van Dam FS. Pain experience and pain management among hospitalized cancer patients. A clinical study. Cancer 1989;63(3):593–8.Google Scholar
  96. 96.
    Josephson KR, Fabacher DA, Rubenstein LZ. Home safety and fall prevention. Clin Geriatr Med 1991;7(4):707–31.PubMedGoogle Scholar
  97. 97.
    Evans RL, et al. Stroke: A family dilemma. Disabil Rehabil 1994;16(3):110–8.PubMedGoogle Scholar
  98. 98.
    Seeman TE, et al. Intercommunity variations in the association between social ties and mortality in the elderly. A comparative analysis of three communities. Ann Epidemiol 1993;3(4):325–35.Google Scholar
  99. 99.
    Oleckno WA, Blacconiere MJ. Relationship of religiosity to wellness and other health-related behaviors and outcomes. Psychol Rep 1991;68(3 Pt 1):819–26.PubMedGoogle Scholar
  100. 100.
    Fillenbaum G. The Duke Older American Resources and Service procedures. In: Multidiminesional Functional Assessment of Older Adults. Lawrence Erlbaum, Hillsdale, NJ. 1988.Google Scholar
  101. 101.
    Aaronson NK, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993;85(5):365–76.PubMedGoogle Scholar
  102. 102.
    Fillenbaum GG, Smyer MA. The development, validity, and reliability of the OARS multidimensional functional assessment questionnaire. J Gerontol 1981;36(4):428–34.PubMedGoogle Scholar
  103. 103.
    Reuben DB, et al. A hierarchical exercise scale to measure function at the Advanced Activities of Daily Living (AADL) level. J Am Geriatr Soc 1990;38(8):855–61.PubMedGoogle Scholar
  104. 104.
    Duke Pain Initiative: Adult pain scales: Thermometer. In: Pain Management Reference Cards. Duke University Medical Center, Durham, NC. 1999.Google Scholar
  105. 105.
    Sherbourne CD, Stewart AL. The MOS social support survey. Soc Sci Med 1991;32(6):705–14.PubMedGoogle Scholar
  106. 106.
    Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983;67(6):361–70.PubMedGoogle Scholar
  107. 107.
    Holland JC, et al. A brief spiritual beliefs inventory for use in quality of life research in life-threatening illness. Psychooncology 1998;7(6):460–9.PubMedGoogle Scholar
  108. 108.
    Lawton MP, Brody EM. Assessment of older people: Self-maintaining and instrumental activities of daily living. Gerontologist 1969;9(3):179–86.PubMedGoogle Scholar
  109. 109.
    Yates JW, Chalmer B, McKegney FP. Evaluation of patients with advanced cancer using the Karnofsky performance status. Cancer 1980;45(8):2220–4.PubMedGoogle Scholar
  110. 110.
    Folstein MF, Folstein SE, McHugh PR. “Mini-mental state.” A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12(3):189–98.PubMedGoogle Scholar
  111. 111.
    Vellas B, et al. The Mini Nutritional Assessment (MNA) and its use in grading the nutritional state of elderly patients. Nutrition 1999;15(2):116–22.PubMedGoogle Scholar
  112. 112.
    Podsiadlo D, Richardson S. The timed “Up & Go”: A test of basic functional mobility for frail elderly persons. J Am Geriatr Soc 1991;39(2):142–8.PubMedGoogle Scholar
  113. 113.
    Loprinzi CL, et al. Prospective evaluation of prognostic variables from patient-completed questionnaires. North Central Cancer Treatment Group. J Clin Oncol 1994;12(3):601–7.PubMedGoogle Scholar
  114. 114.
    Naeim A, Reuben D. Geriatric syndromes and assessment in older cancer patients. Oncology (Williston Park) 2001;15(12):1567–77, 1580; discussion 1581, 1586, 1591.Google Scholar
  115. 115.
    Kawas C, et al. Reliability of the Blessed Telephone Information-Memory-Concentration Test. J Geriatr Psychiatry Neurol 1995;8(4):238–42.PubMedGoogle Scholar
  116. 116.
    Katzman R, et al. Validation of a short orientation-memory-concentration test of cognitive impairment. Am J Psychiatry. 1983;140(6):734–9.PubMedGoogle Scholar
  117. 117.
    Landi F, et al. Body mass index and mortality among older people living in the community. J Am Geriatr Soc 1999;47(9):1072–6.PubMedGoogle Scholar
  118. 118.
    Kempen GI, et al. The assessment of disability with the Groningen Activity Restriction Scale. Conceptual framework and psychometric properties. Soc Sci Med 1996;43(11):1601–10.PubMedGoogle Scholar
  119. 119.
    Cantril H. The Pattern of Human Concerns. Rutgers University Press. New Brunswick, NJ. 1965.Google Scholar
  120. 120.
    de Jong-Gierveld J. Developing and testing a model of loneliness. J Pers Soc Psychol 1987;53(1):119–28.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2009

Authors and Affiliations

  1. 1.Geriatric Oncology Fellow, Department of Hematology and oncology,University of CaliforniaLos AngelesUSA

Personalised recommendations